Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resveratrol as a Preventive Treatment of Ovarian Hyperstimulation Syndrome

NCT03446625 is registered in ClinicalTrials.gov with IVI Madrid as lead sponsor.

NCT NCT03446625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03446625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resveratrol as a Preventive Treatment of Ovarian Hyperstimulation Syndrome
Lead sponsor
IVI Madrid
Phase
Phase 3
Overall status
Completed
Start date
March 13, 2018
Completion date
June 1, 2019
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility